Albine Martin

Albine Martin, Ph.D., is a seasoned leader in the life sciences and biotechnology sectors, currently serving as Co-Founder and Investor at Accelevir Diagnostics since September 2017, focusing on novel assays for HIV-1 persistence and infectious diseases. With extensive experience in evaluating early-stage innovations and commercialization strategies as an Entrepreneur in Residence at Johns Hopkins University since January 2015, and as a member and subject matter expert at New Dominion Angels, Martin has a strong track record in investment opportunities. Previously, as Chief Operating Officer at Precision Biologics, Martin led the launch of a clinical-stage oncology company, and held strategic positions at Compugen Ltd., Thermo Fisher Scientific, and QIAGEN, contributing to successful product development and commercialization initiatives. Martin's academic background includes a Ph.D. in Biochemistry from the University of Maryland and executive education from Harvard Business School, alongside a certificate in Financial Management from Cornell University.